- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06965478
- Original Trial
Systematic Psychophysical (Visuallearning)
November 17, 2025 updated by: Takeo Watanabe, Brown University
Systematic Psychophysical Investigation of Visual Learning
The purpose of this study is to investigate how our performance changes after our perceptual system is trained in a certain way ("perceptual learning").
In addition, investigators are interested in identifying and characterizing relationships between such changes and neuroimaging signals recorded from the human brain.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The long-term goal of the proposed project is to elucidate the underlying mechanisms of visual perceptual learning (VPL) for artificial and natural stimuli, which will be instrumental in developing rehabilitation programs aimed at enhancing damaged or deteriorating vision.
The specificity of VPL to the feature and location of the trained visual stimulus is a fundamental characteristic of VPL.
To investigate the specificity, one effective way is to use an artificial stimulus such as a Gabor patch as the trained stimulus, as it has been widely used to investigate basic visual processing.
Simultaneously, to create an impactful rehabilitation program, the resulting improvements must be generalized to untrained features and locations in visual stimuli encountered in everyday life, including natural scenes (NS).
However, it remains uncertain whether the same mechanisms underlie the generalization and specificity in VPL for artificial and NS stimuli.
In Specific Aim (SA) 1, investigators aim to examine basic mechanism of the specificity using a Gabor patch.
According to a prevailing theory, early visual processing (e.g., 0 to 150ms after the stimulus onset) primarily involves input-level feedforward signals.
In contrast, late processing (e.g.,150-300ms after the stimulus onset) involves recurrent processing.
To better understand the mechanism of the specificity of VPL it is crucial to clarify whether early or late processing is involved.
Additionally, it remains unclear whether the specificity of VPL involves excitation on the trained feature and location or inhibition on untrained features and locations.
Therefore, investigators will test Hypothesis 1 (H1): Late processing (H1-a) or early processing (H1-b) plays a role in the specificity of VPL, and H2: Excitatory signals (H2-a) or inhibitory signals (H2-b) are involved in inducing the specificity of VPL.
investigators will employ two methods.
The backward masking (BM) is used to disrupts and reveal roles of late processing.
In preliminary results, BM applied to the trained orientation eliminated the orientation specificity in VPL, supporting H1-a.
A Rhythmic Synchronization Orientation Decoding Change (RSDC) method is a novel method that examines at which band(s) of rhythmic synchronization from electroencephalogram (EEG) the decoding performances of trained and untrained features and locations change after VPL training.
Preliminary results suggest that trained orientation signals are enhanced at both trained and untrained locations during early processing, while those at untrained locations are inhibited during late processing, leading to the location specificity.
In SA2, investigators will examine the specificity and generalizability of VPL for NS.
Our first step is to test H3: VPL for the dominant orientation in NS is specific (H3-a) or generalized (H3-b) to other orientations.
Preliminary results support H3-b.
If true, investigators will further investigate the aspects in NS that induce the generalization of VPL.
Preliminary result suggests that higher-order statistics, involving correlations between different orientation and spatial frequency channels derived from NS, play a role in the generalization of VPL for NS.
Investigators further aim to test H1 and H2 for NS images, using both the BM and RSDC methods.
Study Type
Interventional
Enrollment (Estimated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Research Assistant
- Phone Number: 401-863-5186
- Email: akiko_norton@brown.edu
Study Contact Backup
- Name: Takeo Watanabe
- Phone Number: 401-863-6916
- Email: takeo_watanabe@brown.edu
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02912
- Recruiting
- Brown University
-
Contact:
- Academic Department Manager
- Phone Number: 401-863-2702
- Email: reinette_sousa@brown.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ages 18 - 60,
- Normal or corrected-to-normal vision
Exclusion Criteria:
- Eye disorders (cataracts, age related macular degeneration, diabetic retinopathy, glaucoma)
- Drug use (psychoactive drugs, neuroleptic medications, prescription medications that might affect cognitive and motor performance)
- Sleep disorders (sleep apnea, insomnia)
- Magnetically or mechanically activated implants (such as cardiac pacemakers)
- clips on blood vessels in the brain
- intrauterine devices
- dentures
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioral measure
Time Frame: From enrollment to the end of treatment at 2 weeks.
|
Changes in rates of correct detection or discrimination in behavioral visual tasks after training are measured.
|
From enrollment to the end of treatment at 2 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 22, 2025
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2029
Study Registration Dates
First Submitted
May 2, 2025
First Submitted That Met QC Criteria
May 2, 2025
First Posted (Actual)
May 11, 2025
Study Record Updates
Last Update Posted (Actual)
November 19, 2025
Last Update Submitted That Met QC Criteria
November 17, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1203000582-02
- R01EY019466 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The types of data to be produced in the current project will be behavioral data and participants' demographic information will also be collected.
All data will be de-identified before receipt by the repository.
Programs for visual stimuli and data analyses will be produced in the project.
IPD Sharing Supporting Information Type
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.